Review
Published on 02 Oct 2023
Pathogenesis and therapeutic implications of EBV-associated epithelial cancers
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1202117
- 3,243 views
- 2 citations
Type at least 3 characters
2,922 articles
Articles
Original Research
Published on 29 Sep 2023
miR-186-ANXA9 signaling inhibits tumorigenesis in breast cancer
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1166666
- 1,843 views
- 2 citations
Original Research
Published on 28 Sep 2023
Mathematical analysis identifies the optimal treatment strategy for epidermal growth factor receptor-mutated non-small cell lung cancer
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1137966
- 2,027 views
Editorial
Published on 28 Sep 2023
Editorial: Preclinical models and emerging technologies to study the effects of the tumor microenvironment on cancer heterogeneity and drug resistance
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1289756
- 1,297 views
Perspective
Published on 26 Sep 2023
Over-expression by degradation rescue of RTKs via cancer-secreted autocrine growth factors: a Phospho-degron-driven actionable layer of post-translational regulation?
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1278402
- 870 views
- 1 citation
Review
Published on 26 Sep 2023
CD98 heavy chain as a prognostic biomarker and target for cancer treatment
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1251100
- 7,074 views
- 8 citations
Review
Published on 26 Sep 2023
Monitoring of single extracellular vesicle heterogeneity in cancer progression and therapy
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1256585
- 3,398 views
- 2 citations
Review
Published on 22 Sep 2023
Nrf2 signaling pathway: current status and potential therapeutic targetable role in human cancers
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1184079
- 9,832 views
- 17 citations
Review
Published on 21 Sep 2023
Evolution by innovation as a driving force to improve TCR-T therapies
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1216829
- 5,585 views
- 1 citation
Review
Published on 20 Sep 2023
Nanotube breakthroughs: unveiling the potential of carbon nanotubes as a dual therapeutic arsenal for Alzheimer’s disease and brain tumors
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1265347
- 3,975 views
- 9 citations
Correction
Published on 20 Sep 2023
Corrigendum: Effects of alkalization therapy on hepatocellular carcinoma: a retrospective study
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1291026
- 657 views
Mini Review
Published on 19 Sep 2023
Post-translational modifications and their implications in cancer
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1240115
- 6,211 views
- 15 citations
Original Research
Published on 19 Sep 2023
Insight of novel biomarkers for papillary thyroid carcinoma through multiomics
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1269751
- 3,343 views
- 1 citation
Mini Review
Published on 18 Sep 2023
Cell-in-cell structure in cancer: evading strategies from anti-cancer therapies
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1248097
- 1,794 views
Original Research
Published on 13 Sep 2023
Tumorigenic effects of human mesenchymal stromal cells and fibroblasts on bladder cancer cells
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1228185
- 2,211 views
- 1 citation
Review
Published on 12 Sep 2023
The multifaceted roles of matrix metalloproteinases in lung cancer
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1195426
- 2,710 views
- 5 citations